Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.
about
Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failureNew challenges of geriatric cardiology: from clinical to preclinical researchEAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors.One-year survival and renal function recovery of acute kidney injury patients with chronic heart failure.Aggravated Cardiac Remodeling post Aortocaval Fistula in Unilateral Nephrectomized Rats.Cardiorenal biomarkers in acute heart failure.Neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with acute heart failure.Causes and treatment of oedema in patients with heart failure.Clinical use of novel biomarkers in heart failure: towards personalized medicine.Epidemiology and importance of renal dysfunction in heart failure patients.Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.Comorbidities in Heart Failure: Are There Gender Differences?Reframing the association and significance of co-morbidities in heart failure.Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.Alcohol Misuse and Kidney Injury: Epidemiological Evidence and Potential Mechanisms.Cardiac resynchronization therapy device implantation guided by electroanatomic mapping system when contrast medium infusion is contraindicated.Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis.Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.Muscle mechanoreflex activation via passive calf stretch causes renal vasoconstriction in healthy humans.Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure.Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.Three-Dimensional Electroanatomic Mapping System-Enhanced Cardiac Resynchronization Therapy Device Implantation: Results From a Multicenter Registry.Non-contrast cardiac resynchronization therapy implantation is feasible in case of renal insufficiency.Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
P2860
Q26796378-53EEDDA7-C173-4B44-A9DC-88C150E1EA6BQ33831628-052440E3-7D5D-40C1-8B2B-3822978AF826Q35035181-3DCE82F4-AC5D-485B-8643-EF3799CAE973Q35081515-4ACF21A6-286A-4AA3-A4EC-4901A09C6945Q35739854-C8177B69-5D02-44B2-AF99-C6EED0FB3DAEQ36313675-B160A569-38AF-498A-A840-FC17B40C7A9CQ37603867-8F10F03D-4C4D-4B7C-BAAA-2FEB35D72155Q38074093-FCEB7BC2-F185-463C-BC21-827151B9BA5BQ38109588-B260C791-0A89-4B73-938B-2399CCCDCBA7Q38149800-65BB9178-7C78-4652-B4FA-E4DED742DA1BQ38383238-75621B27-AF1B-4308-9563-C3D2575B48CAQ38632571-81492B77-93FD-409A-906E-243AB7451E99Q38717849-3DDC757B-AF9F-4ED4-957E-4F2A7B393069Q38881287-CF460B8B-730C-4EE8-9310-76BD5DD4C300Q39247505-E96E0A87-EE52-47F0-9DD8-88A8EA699B1FQ42023592-BF6498C2-9B73-4E41-B282-A3B609EB0FEBQ42175080-7115835A-D017-44E8-858C-5F84B7C5E81BQ42265979-2D5F08BE-5003-4FE8-8E59-D93F788390F1Q45912425-427F7142-6688-4D26-8375-01E03596158AQ48315835-864A38B1-2EEC-45CD-8EC8-5BCBE95562D4Q48437939-B393E18F-9C67-4EB3-98A0-86EF0408C661Q50634411-9F5B91D6-0257-4AB4-B104-5842E501CBD3Q51060191-5DB00BA4-25F2-42EB-AE27-35747F9911CAQ53466453-C6EEB983-33C8-4140-8580-CDEE52F189EFQ53539379-782851C7-1CF4-40C4-94B0-309F0A8AFC3B
P2860
Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@en
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@nl
type
label
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@en
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@nl
prefLabel
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@en
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@nl
P2093
P2860
P1476
Renal dysfunction in acute and ...... ence, incidence and prognosis.
@en
P2093
Ashraf Yassin
Renjith Antony
Teresa Castiello
Valentina Carubelli
P2860
P2888
P304
P356
10.1007/S10741-012-9306-2
P577
2012-03-01T00:00:00Z